Trials / Completed
CompletedNCT01107353
Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Imipramine Pamoate Capsules, 75 mg, Under Fasted Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Imipramine Pamoate 75 mg Capsules under fasting conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imipramine Pamoate | 75 mg capsule |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2010-04-20
- Last updated
- 2018-02-05
- Results posted
- 2014-01-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01107353. Inclusion in this directory is not an endorsement.